Aptamer Group (LON:APTA) Stock Price Down 6.7% – Should You Sell?

Aptamer Group plc (LON:APTA)’s share price traded down 6.7% during trading on Friday . The company traded as low as GBX 1.02 ($0.01) and last traded at GBX 1.05 ($0.01). 7,978,599 shares were traded during trading, a decline of 56% from the average session volume of 18,061,879 shares. The stock had previously closed at GBX 1.13 ($0.02).

Aptamer Group Stock Down 10.2%

The business has a fifty day moving average of GBX 0.86 and a 200 day moving average of GBX 0.52. The firm has a market cap of £27.24 million, a P/E ratio of -360.71 and a beta of -0.52.

Insider Transactions at Aptamer Group

In related news, insider Adam Hargreaves acquired 5,000,000 shares of the firm’s stock in a transaction dated Monday, September 8th. The stock was acquired at an average price of GBX 1 per share, with a total value of £50,000. 8.76% of the stock is owned by corporate insiders.

About Aptamer Group

Aptamer Group is a leading provider of aptamer selection services and developer of aptamer-based reagents for use in research, bioprocessing, diagnostic, and therapeutic applications. Headquartered in York, UK, the Company partners globally to deliver aptamer-based solutions that drive discovery and development across the life sciences.

Aptamer Group has developed the proprietary Optimer® platform technology that drives three distinct businesses: Aptamer Solutions, Aptamer Diagnostics and Aptamer Therapeutics.